PRINCIPLES OF THERAPY FOR CONSTIPATION IN PREGNANT WOMEN
- Авторлар: SOLOVYEVA A.V1
-
Мекемелер:
- Peoples' Friendship University of Russia
- Шығарылым: № 4 (2013)
- Беттер: 58-60
- Бөлім: Articles
- URL: https://journals.eco-vector.com/0300-9092/article/view/246954
- ID: 246954
Дәйексөз келтіру
Ашық рұқсат
Рұқсат берілді
Аннотация
Objective. To study the clinical efficacy of duphalac in pregnant women with constipation. Subject and methods. Examinations were made in 63 pregnant women in the first, second, and third trimesters and in the postpartum period: 28 pregnant women with constipation that had first occurred during pregnancy and 35 pregnant women with constipation that had occurred before pregnancy. All the pregnant women received duphalac in a dose of 10-40 ml/day for 15 days. Results. Intestinal transit was restored in 100% of cases. Premature birth occurred in 1 patient at 34-35 weeks gestation; the baby was alive. Sixty-two full-term healthy babies were born, who were discharged on days 3-5. There were no pyoseptic complications during the postpartum period. Conclusion. Duphalac not only effectively restores the transit of intestinal contents, but also promotes recovery of the normal vaginal biotope and no pyoseptic complications in the postpartum period.
Негізгі сөздер
Толық мәтін
Әдебиет тізімі
- Маев И.В. Хронический запор. Лечащий врач. 2001; 7: 53-9.
- Парфенов А.И. Профилактика и лечение запоров у беременных. Гинекология. 2002; 4(3): 14-7.
- Зайдиева З.С., Лукьянова Е.В. Профилактика и терапия запора при беременности. Российский медицинский журнал. 2010; 18(4): 209-12.
- Гвасалия А.Г. Клиническое лечение запоров: Автореф. дис.. канд. мед. наук. М.; 2004. 23с.
- Бондаренко В.М., Рябиченко Е.В. Роль транслокации кишечной бактериальной аутофлоры и ее токсичных биомолекул в патологии человека. Экспериментальная и клиническая гастроэнтерология. 2007; 5: 86-93.
- Радзинский В.Е., Оразмурадов А.А., ред. Ранние сроки беременности. 2-е изд. М.: Status Praesens; 2009. 480c.
Қосымша файлдар
